Fig. 2From: Mesenchymal stem cells and extracellular vesicles in therapy against kidney diseasesFunctional pathways of MSC-EVs in different AKI models. MSC-EVs can relieve AKI by inhibiting oxidation, apoptosis, and inflammation and regulating angiogenesis, cell cycle, regeneration, autophagy, and proliferation. MSCs, mesenchymal stem cells; EVs, extracellular vesicles; AKI, acute kidney injury; I/R, ischaemia-reperfusion; CLP, caecal ligation and punctureBack to article page